External broker reports(aggregated public sources), TA Securities Holdings Berhad

TA Securities Holdings Bhd

External broker reports(aggregated public sources)

Equity Bottom-Up

<div class="content-highlight"><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></div>

Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Malaysia

Duopharma Biotech Berhad operates as a pharmaceutical company. The Company discovers and markets generic drugs. Duopharma Biotech serves customers in Malaysia.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Duopharma Biotech (DBB MK)

Approval to Import Sinopharm Vaccine

Sell Ccm Duopharma Biotech Berhad: Approval to Import Sinopharm Vaccine. - By: TA Securities Holdings Bhd

TA Securities Holdings Bhd

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)